Research funder · United States
Children's Tumor Foundation
Foundation dedicated to improving the health and well-being of individuals and families affected by neurofibromatosis
- Grants since 2016
- 436
- Awarded, last 5 years (where amounts are published)
- 28.1M
- Funded works, last 5 years
- 115
- Funded works, all time
- 426
Grants
2023–2026 · award
Multiomic integration to identify schwannomatosis predisposition genes and tumorigenesis
Antonio Iavarone · Sylvester Comprehensive Cancer Center
2023–2026 · award
Repurposing anti-retroviral drugs to treat NF2 related tumours
Clemens Hanemann · University of Plymouth
2023–2026 · award
Developing an AAV-based genome editing approach for the treatment of NF2
Lars Björn Riecken · Children's Medical Research Institute
2023–2025 · award
A skeletal stem cell basis and novel therapeutic approaches for fracture healing defects in Neurofibromatosis type 1
Jun Sun · Weill Cornell Medicine
2023–2024 · award
Developing NF2 iPSC-cell models for the use of antisense oligonucleotides as a personalized therapy for Neurofibromatosis Type 2 patients
Elisabeth Castellanos-Perez · Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
2023–2024 · award
Development of cell penetrating peptides targeting the Yap/Tead complex in the context of Neurofibromatosis type 2
Dominique Lallemand · Inserm
2023–2025 · award
Phase 1/2 clinical trial of PRG-N-01 and data collection by MRI in NF2 patients
Bum-Joon Park · Pusan National University
2023–2024 · award
Creation of a Disease-Specific Measure of Self-Care for Adults with Neurofibromatosis I - A Mixed-Methods Study
Diane Zelman · Alliant University
2023–2025 · award
Role of Schwann cells in NF1-related pain development
Michael Jankowski · Children's Hospital Medical Center
2023–2024 · award
Targeted delivery of gene replacement therapy for NF1 plexiform neurofibromas
Jiangbing Zhou · Yale University
2023–2025 · award
Nanopore-based genomic analysis of minimally invasive biopsies of ANNUBP and MPNST for better diagnostics and management
Bernat Gel · Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
2023–2025 · award
CENPF as a biomarker and therapeutic target for NF1-associated MPNST
Aditya Sheth · Indiana University Indianapolis
2023–2025 · award
To understand the role of Apelin mediated angiogenesis in NF2 associated tumors
Srirupa Bhattacharyya · Brigham and Women's Hospital
2023–2025 · award
Co-Targeting HMGB1 and EGF signaling for the treatment of NF2 and associated hearing loss
Zhenzhen Yin · Massachusetts General Hospital
2023–2025 · award
Investigating the link between sensory and social deficits in a Drosophila model of Neurofibromatosis type I
Jadwiga Bilchak · University of Pennsylvania
2023–2025 · award
Cognitive aging in middle-aged and older adults with neurofibromatosis type 1: Patterns and predictors
Yang Hou · National Cancer Institute
2023–2024 · award
Supplementing The Children’s Tumor Foundation-Neurofibromatosis Registry with Electronic Health Record Dataset from Mayo Clinic Rochester
Mayowa Osundiji · Mayo Clinic Hospital
2023–2025 · award
Tumor:Macrophage Interactions in Schwannoma
Sara Veiga · Massachusetts General Hospital
2023–2025 · award
Dissecting DGCR8 syndrome and the molecular mechanisms driving DGCR8-associated schwannomatosis
Clara Nogué I Ansón · Institut d'Investigació Biomédica de Bellvitge
2023–2025 · award
Demonstrating Clinical Benefit of New Treatments for NF2-related schwannomatosis: Developing A More Comprehensive and Sensitive Measure of Quality of Life for NF2 Clinical Trials
Vanessa Merker · Massachusetts General Hospital
2023–2025 · award
Mechanisms of MPNST Metastasis
Alexa Sheehan · University of Iowa
2023–2025 · award
Mechanisms of LZTR1-mediated schwannomatosis pain
Andrei Sdrulla · Oregon Health & Science University
2023–2024 · award
Patient-derived plexiform neurofibromas organoid model for drug repositioning in precision medicine
Nicholas Boulis · Emory University
2023–2025 · award
Risk factors and characteristics of NF1-associated cancer
Roope Kallionpää · University of Turku
2023–2024 · award
Development of Nanobody-decorated Bacterial Outer Membrane Vesicles for Schwannoma Immunotherapy
Sherif Ahmed · Massachusetts General Hospital
2022–2024 · award
Study of NF1 in Families
Margaret Wallace · University of Florida
2022–2024 · award
Evaluation of BRD4 Inhibitors for Use in Combination with Kinase Inhibitors for NF2 Schwannomas
Haley Hardin · University of Central Florida
2022–2023 · award
Characterization of novel bioengineered vectors targeting Schwann cells in a non-human primate model for human gene therapies
Samantha Ginn · The University of Sydney
2022 · award
Targeting combined MEK and HDAC inhibition as an effective therapeutic strategy for NF1 high-grade glioma
Thomas De Raedt · Children's Hospital of Philadelphia
2022–2024 · award
Effectiveness of a Telehealth Group for Improving Peer Relationships for Adolescents with Neurofibromatosis Type 1: Feasibility of Multisite Collaboration
Bonita Klein-Tasman · Twin Cities Orthopedics
2022–2024 · award
Study of NF1 in Families
Margaret Wallace · University of Florida
2022–2025 · award
Utilization of Cell Free DNA Liquid Biopsy for Diagnosis and Monitoring of Tumor Evolution in MPNST
Angela Hirbe · Washington University in St. Louis
2022–2024 · award
The Impact of Self-Determination Theory on Increasing Health-Promoting Behaviors in Adults with Neurofibromatosis Type 1
Erica Leif · Alliant University
2022–2023 · award
In vivo testing of AXL inhibitor BGB324, and MERTK inhibitors UNC2025 and MRX2843 in the Postn-Cre; Nf2flox/flox mouse model of schwannoma
Sylwia Ammoun · University of Plymouth
2022–2024 · award
Development of the adult UAMS NF Clinic (Pilot Project)
Erika Santos Horta · University of Arkansas for Medical Sciences
2022–2024 · award
Characterization of the molecular mechanisms conferring resistance to treatment on NF1 associated-MPNST.
Charlene Iltis · Memorial Sloan Kettering Cancer Center
2022–2023 · award
Combined inhibition of MEK and BMI-1 for the treatment of NF1 associated High Grade Glioma
Thomas De Raedt · Children's Hospital of Philadelphia
2022–2024 · award
Federated deep-learning platform for volumetric quantification of tumor burden in patients with neurofibromatosis on whole-body MRI
Wenli Cai · Massachusetts General Hospital
2022–2024 · award
The role of Schwann cells in the onset of pain due to neurofibromatosis-1 (NF1)
Namrata Raut · Cincinnati Children's Hospital Medical Center
2022 · award
Targeting endothelial cell to macrophage communication in NF1 tumors
Brian Stansfield · Augusta University